4.6 Review

Causes and treatment of oedema in patients with heart failure

Journal

NATURE REVIEWS CARDIOLOGY
Volume 10, Issue 3, Pages 156-170

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrcardio.2012.191

Keywords

-

Funding

  1. National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish

Ask authors/readers for more resources

Oedema is one of the fundamental features of heart failure, but the pathophysiology of oedema varies. Patients present along a spectrum ranging from acute pulmonary oedema to gross fluid retention and peripheral oedema (anasarca). In patients with pure pulmonary oedema, the problem is one of acute haemodynamic derangement; the patient does not have excess fluid, but pulmonary venous pressure rises such that the rate of fluid transudation into the interstitium of the lung exceeds the capacity of the pulmonary lymphatics to drain away the fluid. Conversely, in patients with peripheral oedema, the problem is one of fluid retention. Understanding the causes of oedema will enable straightforward, correct management of the condition. For patients with acute pulmonary oedema, vasodilatation is important to reduce cardiac filling pressures. For patients with fluid retention, removing the fluid, using either diuretics or mechanical means, is the most important consideration. Clark, A. L. & Cleland, J. G. F. Nat. Rev. Cardiol. 10, 156-170; published online 15 January 2013; doi: 10.1038/nrcardio.2012.191

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF

Wouter Ouwerkerk, Jasper Tromp, John G. F. Cleland, Christiane E. Angermann, Ulf Dahlstrom, Georg Ertl, Mahmoud Hassanein, Sergio Perrone, Mathieu Ghadanfar, Anja Schweizer, Achim Obergfell, Kenneth Dickstein, Gerasimos Filippatos, Sean P. Collins, Carolyn S. P. Lam

Summary: In patients with acute heart failure, delayed administration of intravenous diuretics was not significantly associated with in-hospital mortality, but was associated with increased 30-day mortality, especially in high-risk patients. This association was independent of left ventricular ejection fraction or geographic region.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial

Zachary I. Whinnett, Matthew J. Shun-Shin, Mark Tanner, Paul Foley, Badri Chandrasekaran, Philip Moore, Shaumik Adhya, Norman Qureshi, Amal Muthumala, Rebecca Lane, Aldo Rinaldi, Sharad Agarwal, Francisco Leyva, Jonathan Behar, Sukh Bassi, Andre Ng, Paul Scott, Rachana Prasad, Jon Swinburn, Joseph Tomson, Amarjit Sethi, Jaymin Shah, Phang Boon Lim, Andreas Kyriacou, Dewi Thomas, Jenny Chuen, Ravi Kamdar, Prapa Kanagaratnam, Myril Mariveles, Leah Burden, Katherine March, James P. Howard, Ahran Arnold, Pugazhendhi Vijayaraman, Berthold Stegemann, Nicholas Johnson, Emanuela Falaschetti, Darrel P. Francis, John G. F. Cleland, Daniel Keene

Summary: The study evaluated the effects of optimized His bundle pacing compared to no-pacing in patients with heart failure. It was found that His bundle pacing significantly improved quality of life and was preferred by the majority of patients. However, it did not show any significant changes in peak oxygen uptake or left ventricular ejection fraction.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials

Joao Pedro Ferreirra, John G. Cleland, Nicolas Girerd, Patrick Rossignol, Pierpaolo Pellicori, Franco Cosmi, Beatrice Mariottoni, Arantxa Gonzalez, Javier Diez, Scott D. Solomon, Brian Claggett, Marc A. Pfeffer, Bertram Pitt, Johannes Petutschnigg, Burkert Pieske, Frank Edelmann, Faiez Zannad

Summary: Spironolactone reduces serum concentrations of PICP in patients with HFpEF, indicating its anti-fibrotic effect.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Combining Iron Supplements With SGLT2 Inhibitor- Stimulated Erythropoiesis in Heart Failure: Should We Be Worried About Thromboembolic Events?

Milton Packer, John G. F. Cleland

JOURNAL OF CARDIAC FAILURE (2023)

Article Cardiac & Cardiovascular Systems

The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure

Nicola Riccardo Pugliese, Pierpaolo Pellicori, Francesco Filidei, Lavinia Del Punta, Nicolo De Biase, Alessio Balletti, Valerio Di Fiore, Alessandro Mengozzi, Stefano Taddei, Luna Gargani, Wilfried Mullens, John G. F. Cleland, Stefano Masi

Summary: This study investigated the prevalence and clinical value of assessing multi-organ congestion by ultrasound in heart failure outpatients. It found that patients with multiple ultrasound signs of congestion had the worst prognosis.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2023)

Article Cardiac & Cardiovascular Systems

Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)

Joao Pedro Ferreira, John G. F. Cleland, Nicolas Girerd, Pierpaolo Pellicori, Mark R. Hazebroek, Job Verdonschot, Timothy J. Collier, Johannes Petutschnigg, Andrew L. Clark, Jan A. Staessen, Stephane Heymans, Patrick Rossignol, Faiez Zannad

Summary: The study investigated the effect of spironolactone on QRS duration in patients with stage B HFpEF. Spironolactone was found to significantly reduce the QRS duration after 9 months of treatment, indicating improved myocardial electrical activation. This effect was not associated with changes in LV mass or volume.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure

George Markousis-Mavrogenis, Waldemar B. Minich, Ali A. Al-Mubarak, Stefan D. Anker, John G. F. Cleland, Kenneth Dickstein, Chim C. Lang, Leong L. Ng, Nilesh J. Samani, Faiez Zannad, Marco Metra, Petra Seemann, Antonia Hoeg, Patricio Lopez, Dirk J. van Veldhuisen, Rudolf A. de Boer, Adriaan A. Voors, Peter van der Meer, Lutz Schomburg, Nils Bomer

Summary: The study examined the importance of autoantibodies against adrenergic/muscarinic receptors in heart failure. The findings suggest that anti-beta 1 AABs are independently associated with HF rehospitalization, while other AABs are mainly related to comorbidities and medication use.

CARDIOVASCULAR RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

Nicolas Girerd, Daniel Levy, Kevin Duarte, Joao Pedro Ferreira, Christie Ballantyne, Timothy Collier, Anne Pizard, Jens Bjoerkman, Javed Butler, Andrew Clark, John G. Cleland, Christian Delles, Javier Diez, Arantxa Gonzalez, Mark Hazebroek, Jennifer Ho, Anne-Cecile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A. Staessen, Job Verdonschot, Stephane Heymans, Patrick Rossignol, Faiez Zannad

Summary: This study identified protein biomarkers associated with new-onset heart failure in three independent cohorts. The inclusion of these biomarkers in addition to clinical risk factors improved the prediction of heart failure risk. The B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide were found to be particularly relevant in predicting heart failure.

CIRCULATION-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity

Antonio Iaconelli, Joe Cuthbert, Syed Kazmi, Pasquale Maffia, Andrew L. Clark, John G. F. Cleland, Pierpaolo Pellicori

Summary: This study found that venous congestion is more closely associated with prognosis in patients with chronic heart failure than pulmonary hypertension.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Redefining both iron deficiency and anaemia in cardiovascular disease

John G. F. Cleland, Pierpaolo Pellicori, Fraser J. Graham

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis

Fraser J. J. Graham, Pierpaolo Pellicori, Paul R. R. Kalra, Ian Ford, Dario Bruzzese, John G. F. Cleland

Summary: This meta-analysis investigates the effect of intravenous iron on clinical outcomes in patients with heart failure. The results suggest that intravenous iron reduces the risk of recurrent heart failure and cardiovascular death, but its impact on cardiovascular and all-cause mortality is inconclusive.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF

Dimitrios Farmakis, Jasper Tromp, Smaragdi Marinaki, Wouter Ouwerkerk, Christiane E. E. Angermann, Vasiliki Bistola, Ulf Dahlstrom, Kenneth Dickstein, Georg Ertl, Mathieu Ghadanfar, Mahmoud Hassanein, Achim Obergfell, Sergio V. V. Perrone, Eftihia Polyzogopoulou, Anja Schweizer, Ioannis Boletis, John G. F. Cleland, Sean P. P. Collins, Carolyn S. P. Lam, Gerasimos Filippatos

Summary: This study analyzed healthcare resource utilization in patients with heart failure of different ejection fraction types and found high utilization across all three groups. Despite clinical differences, patients with HFmrEF and HFpEF had better long-term cardiovascular outcomes compared to HFrEF. However, the risk for non-cardiovascular events was similar among the groups.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Letter Cardiac & Cardiovascular Systems

Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis

Vincenzo C. C. Leo, Syed Kazmi, Jack Brownrigg, Marzieh Araghi, Harpreet S. S. Sarna, Pierpaolo Pellicori, Joe Cuthbert, John G. F. Cleland, Andrew L. L. Clark

ESC HEART FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?

Joe J. Cuthbert, John G. F. Cleland

CARDIOVASCULAR RESEARCH (2023)

Letter Cardiac & Cardiovascular Systems

Hypocapnia is an independent predictor of in-hospital mortality in acute heart failure

Alberto Guarnaccia, Gianfranco Sinagra, John G. F. Cleland

ESC HEART FAILURE (2023)

No Data Available